Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice

Neuroscience

Volumn 151, Issue 2, 2008, Pages 613-621

  Smittkamp, S E ^a   Brown, J W ^b   Stanford, J A ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

bulbar; familial ALS; G1H; grip strength; operant behavioral task; tongue

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BULBAR PARALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCE; GRIP STRENGTH; INSTRUMENTAL CONDITIONING; LIMB WEAKNESS; LOCOMOTION; MEASUREMENT; MORBIDITY; MORTALITY; MOTONEURON; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; MOUTH; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; SYMPTOM; TASK PERFORMANCE; TONGUE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; HAND STRENGTH; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MOUTH; MOVEMENT DISORDERS; MUSCULOSKELETAL EQUILIBRIUM; PHENOTYPE; SPINAL CORD; SUPEROXIDE DISMUTASE; TONGUE;

EID: 37849014246     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.10.017     Document Type: Article

References (43)

1. Angenstein F., Niessen H.G., Goldschmidt J., Vielhaber S., Ludolph A.C., and Scheich H. Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. Neuroreport 15 (2004) 2271-2274
2. G93A G1H mouse model of familial amyotrophic lateral sclerosis. Brain Res 982 (2003) 92-97
3. Baloh R.H., Rakowicz W., Gardner R., and Pestronk A. Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromes. Muscle Nerve 36 (2007) 107-110
4. Canton T., Bohme G.A., Boireau A., Bordier F., Mignani S., Jimonet P., Jahn G., Alavijeh M., Stygall J., Roberts S., Brealey C., Vuilhorgne M., Debono M.-W., Le Guern S., Laville M., Briet D., Roux M., Stutzmann J.-M., and Pratt J. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. J Pharmacol Exp Ther 299 (2001) 314-322
5. Canton T., Pratt J., Stutzmann J.-M., Imperato A., and Boireau A. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 9 (1998) 775-778
6. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., and Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6 (1995) 349-362
7. Dal Canto M.C., and Gurney M.E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145 (1994) 1271-1279
8. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., and Hung W.Y. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261 (1993) 1047-1051
9. DePaul R., Abbs J.H., Caligiuri M., Gracco V.L., and Brooks B.R. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 38 (1988) 281-283
10. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., and Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods 107 (2001) 107-124
11. Fowler S.C., and Wang G. Chronic haloperidol produces a time- and dose-related slowing of lick rhythm in rats: implications for rodent models of tardive dyskinesia and neuroleptic-induced parkinsonism. Psychopharmacology (Berl) 137 (1998) 50-60
12. Frey D., Schneider C., Xu L., Borg J., Spooren W., and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20 (2000) 2534-2542
13. Guo H., Lai L., Butchbach M.E.R., Stockinger M.P., Shan X., Bishop G.A., and Lin C.-L.G. Increased expression of the glial glutamate transport EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 12 (2003) 2519-2532
14. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
15. Haenggeli C., and Kato A.C. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci Lett 335 (2002) 39-43
16. Hegedus J., Putman C.T., and Gordon T. Time course of preferential motor unit loss in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2007) doi:10.1016/j.nbd.2007.07.003
17. Horowitz G.P., Stephan F.K., Smith J.C., and Whitney G. Genetic and environmental variability in lick rates of mice. Physiol Behav 19 (1977) 493-496
18. Hottinger A.F., Fine E.G., Gurney M.E., Zurn A.D., and Aebischer P. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 9 (1997) 1548-1551
19. Kasarkis E.J., Berryman S., Vanderleest J.G., Schneider A.R., and McClain C.J. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 63 (1996) 130-137
20. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., and Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 (2003) 839-842
21. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18 (1998) 3241-3250
22. Krivickas L.S., Yang J.-I., Kim S.-K., and Frontera W.R. Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 636-643
23. Langmore S.E., and Lehman M.E. Physiologic deficits in the orofacial system underlying dysarthria in amyotrophic lateral sclerosis. J Speech Hear Res 37 (1994) 28-37
24. Miana-Mena F.J., Munoz M.J., Yague G., Mendez M., Moreno M., Ciriza J., Zaragoza P., and Osta R. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 6 (2005) 55-62
25. Millecamps S., Nicolle D., Ceballos-Picot I., Mallet J., and Barkats M. Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci U S A 98 (2001) 7582-7587
26. Mitsumoto H., Chad D.A., and Pioro E.P. Amyotrophic lateral sclerosis (1998), FA Davis Company, Philadelphia, PA
27. Murakami H. Rhythmometry on licking rate of the mouse. Physiol Behav 19 (1977) 735-738
28. Nau K.L., Bromberg M.B., Forshew D.A., and Katch V.L. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 129 (1995) 47-49
29. Niessen H.G., Angenstein F., Sander K., Kunz W.S., Teuchert M., Ludolph A.C., Heinze H.-J., Scheich H., and Vielhaber S. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Exp Neurol 201 (2006) 293-300
30. Nimchinsky E.A., Young W.G., Yeung G., Shah R.A., Gordon J.W., Bloom F.E., Morrison J.H., and Hof P.R. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J Comp Neurol 416 (2000) 112-125
31. Pun S., Santos A.F., Saxena S., Xu L., and Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9 (2006) 408-419
32. Rosen A.D. Amyotrophic lateral sclerosis: clinical features and prognosis. Arch Neurol 35 (1978) 638-642
33. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364 (1993) 362
34. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1701
35. Sharp P.S., Dick J.R.T., and Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 130 (2005) 897-910
36. Silani V., Kasarskis E.J., and Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a world-wide perspective. J Neurol 245 (1998) S13-S19
37. Tankersley C.G., Haenggeli C., and Rothstein J.D. Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. J Appl Physiol 102 (2007) 926-932
38. Travers J.B., Dinardo L.A., and Karimnamazi H. Motor and premotor mechanisms of licking. Neurosci Biobehav Rev 21 (1997) 631-647
39. Veldink J.H., Bar P.R., Joosten E.A., Otten M., Wokke J.H., and van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 13 (2003) 737-743
40. Wang G., and Fowler S.C. Effects of haloperidol and clozapine on tongue dynamics during licking in CD-1, BALB/c and C57BL/6 mice. Psychopharmacology 147 (1999) 38-45
41. Weydt P., Hong S.Y., Kliot M., and Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14 (2003) 1051-1054
42. m for hydrogen peroxide. Proc Natl Acad Sci U S A 93 (1996) 5709-5714
43. G93A G1H transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 332 (2002) 99-102